Tag: FDA/CDER-AACR-IASLC-IASLC Workshop
Oncology Trials Could Benefit From Increased Data on Tobacco Use
By Leah Lawrence
Posted: June 24, 2020
As part of its declaration on tobacco cessation after cancer diagnosis, the IASLC recommended that smoking status, both initially...
IASLC’s Inaugural Mesothelioma Meeting Sets Baseline for Strategic Approach to Patient...
Posted: November 15, 2019
As a rare orphan disease, mesothelioma research has been slowed by a lack of eligible patients for trials and by a...
